Skip to main content
E-mail : pharmce@uic.edu
English ‎(en)‎
English ‎(en)‎ English (United States) ‎(en_us)‎
Log in
Pharmacy CE
Home
Pharmacy CE
  • Home
  • More
  1. Courses
  2. Pharmacists
  3. NASP
  4. NASP 2025 Conference Homestudies-Pharmacist
  5. Main Conference

Main Conference

Precision Medicine in Breast Cancer: The Future of Oral Oncology
2025 US Specialty Pharmaceutical Trends, Issues and Outlook
ISMP Update 2025: Rocky Mountain Safety using Key Elements and Best Practices to Prevent Errors
Gene Therapy, the success story of a patient and healthcare partner dependencies
Rare Disease Therapeutics 2025: Tracking Tomorrow's Breakthrough
NASP 2025/Adapting for a More Dynamic Future
State of Care: Evolving Treatments for Acute and Chronic Gout
2025 Oncology Market Trends and Pipeline Update
“What’s in the box?!” Decreasing Medication Errors in the Last Mile
Specialty Pharmacy and an Aging Population Panel Discussion
Fraud, Waste, and Abuse in Specialty Pharmacy: Key Risk Areas and Strategies for Compliance
Embracing Biosimilars: Overcoming Barriers to Adoption
Specialty Pipeline Therapies: 2025 Update
Breaking Barriers: Addressing Implicit Bias and Social Determinants of Health in Specialty Pharmacy
Hidradenitis Suppurativa Decoded: From Pathophysiology to Personalized Care
Academi

All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date. Pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of each activity. For more information and to set up your e-Profile visit: CPE Monitor.

Info

    UIC College of PharmacyOffice of Continuing Education and Meeting ServicesPrivacy PolicyHardware/Software/Internet RequirementsFrequently Asked Questions

Contact Us

833 S. Wood St. Suite B12, Chicago, Illinois, 60612 (MC 886)

Email : pharmce@uic.edu

Follow Us

Copyright © 2025- The Board of Trustees of the University of Illinois

You are not logged in. (Log in)
Data retention summary
Powered by Moodle